Episode
Decisions That Made Me: Harry Destecroix (Ziylo, Science Creates, SCVC)
- Podcast
- The Bottom Line
- Published
- Dec 4, 2025
- Duration seconds
- 866
- Processing state
not_requested- Canonical source
- http://www.bbc.co.uk/programmes/p0mljdfv
Actions
POST https://stenobird.com/v1/public/podcasts/the-bottom-line-1067438/episodes/decisions-that-made-me-harry-destecroix-ziylo-science-creates-scvc/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-bottom-line-1067438/decisions-that-made-me-harry-destecroix-ziylo-science-creates-scvc.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Harry Destecroix was studying for his PhD at Bristol University when he co-founded Ziylo. Based on 20 years of Bristol chemistry research, the spin-out company created a new technology that can be developed to treat diabetes more effectively. It's a breakthrough that led to its acquisition by pharmaceutical firm, Novo Nordisk, in a deal reportedly worth up to 600 million pounds. Harry has also founded the incubator, Science Creates and is the founding managing partner of SCVC, a venture capital firm. Harry tells Evan Davis why his own experience of spinning out a company has made him passionate to help other early-stage companies in the Bristol area – whether that’s providing lab space, finance or advice. (Image: Harry Destecroix Credit: Peter Schiazza, Copyright: Science Creates)